The splice of life: Alternative splicing and neurological disease

Nature Reviews Neuroscience

Volumn 2, Issue 1, 2001, Pages 43-50

  Dredge, B Kate ^a   Polydorides, Alexandros D ^a   Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA BINDING PROTEIN; RNA PRECURSOR;

ALTERNATIVE RNA SPLICING; ANIMAL; BRAIN; GENETICS; HUMAN; METABOLISM; NERVE CELL; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; HUMANS; NERVOUS SYSTEM DISEASES; NEURONS; RNA PRECURSORS; RNA-BINDING PROTEINS;

EID: 0035230130     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/35049061     Document Type: Article

References (97)

1. Lin, Z., Haus, S., Edgerton, J. & Lipscombe, D. Identification of functionally distinct isoforms of the N-type Ca2+ channel inrat sympathetic ganglia and brain. Neuron 18, 153–166 (1997).
2. Ehlers, M. D., Tingley, W. G. & Huganir, R. L. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science 269, 1734–1737 (1995).
3. Macdonald, R. L. Ethanol, γ-aminobutyrate type A receptors, and protein kinase C phosphorylation. Proc. Natl Acad. Sci. USA 92, 3633–3635 (1995).
4. Picetti, R. et al. Dopamine D2 receptors in signal transduction and behavior. Crit. Rev. Neurobiol. 11, 121–142 (1997).
5. Conn, P. J. & Pin, J. P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205–237 (1997).
6. Stamm, S., Zhang, M. Q., Marr, T. G. & Helfman, D. M. A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res. 22, 1515-1526 (1994).
7. Amara, S. G., Jonas, V, Rosenfeld, M. G., Ong, E. S. & Evans, R. M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298, 240-244 (1982).
8. Buckanovich, R. J., Posner, J. B. & Darnell, R. B. Nova, the paraneoplastic Ri antigen, is homologous to an RNA- binding protein and is specifically expressed in the developing motor system. Neuron 11, 657-672 (1993).
9. Jensen, K. B. et al. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25, 359-371 (2000).
10. Hutton, M. et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705 (1998).
11. Spillantini, M. G. et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741 (1998).
12. Hong, M. et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917 (1998).
13. Poorkaj, P et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825 (1998).
14. Hasegawa, M., Smith, M. J. & Goedert, M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210 (1998).
15. D'Souza, I. et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism- chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl Acad. Sci. USA 96, 5598-5603 (1999).
16. Goedert, M. & Spillantini, M. G. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim. Biophys. Acta 1502, 110-121 (2000).
17. Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J. & Crowther, R. A. Cloning and sequencing of the cDNA encoding an isoform of microtubule- associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393-399 (1993).
18. Kosik, K. S., Orecchio, L. D., Bakalis, S. & Neve, R. L. Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397 (1989).
19. Grover, A. et al. 5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon. J. Biol. Chem. 274, 15134-15143 (1999).
20. Jiang, Z., Cote, J., Kwon, J. M., Goate, A. M. & Wu, J. Y. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol. Cell. Biol. 20, 4036-4048 (2000).
21. Ishihara, T. et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762 (1999).
22. Brzustowicz, L. M. et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344, 540-541 (1990).
23. Melki, J. et al. Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 344, 767-768 (1990).
24. Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165 (1995).
25. Liu, Q. & Dreyfuss, G. A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15, 3555-3565 (1996).
26. Pellizzoni, L., Kataoka, N., Charroux, B. & Dreyfuss, G. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95, 615-624 (1998).
27. Pellizzoni, L., Charroux, B. & Dreyfuss, G. SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc. Natl Acad. Sci. USA 96, 11167-11172 (1999).
28. Lorson, C. L. et al. SMN oligomerization defect correlates with spinal muscular atrophy severity. Nature Genet. 19, 63-66 (1998).
29. Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMNgene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307-6311 (1999).
30. Lorson, C. L. & Androphy, E. J. An exonic enhancer is required for inclusion of an essential exon in the SMA- determining gene SMN. Hum. Mol. Genet. 9, 259-265 (2000).
31. Brown, R. H. Jr. Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments. Ann. Neurol. 39, 145-146 (1996).
32. Siddique, T. & Deng, H. X. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5, 1465-1470 (1996).
33. Rothstein, J. D., Martin, L. J. & Kuncl, R. W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468 (1992).
34. Rothstein, J. D. et al. Localization of neuronal and glial glutamate transporters. Neuron 13, 713-725 (1994).
35. Shaw, P. J., Forrest, V., Ince, P. G., Richardson, J. P. & Wastell, H. J. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4, 209-216 (1995).
36. Lin, C. L. et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602 (1998).
37. Meyer, T. et al. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 170, 45-50 (1999).
38. Honig, L. S., Chambliss, D. D., Bigio, E. H., Carroll, S. L. & Elliott, J. L. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 55, 1082-1088 (2000).
39. Koob, M. D. et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nature Genet. 21, 379-384 (1999).
40. Taneja, K. L., McCurrach, M., Schalling, M., Housman, D. & Singer, R. H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995-1002 (1995).
41. Davis, B. M., McCurrach, M. E., Taneja, K. L., Singer, R. H. & Housman, D. E. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA 94, 7388-7393 (1997).
42. Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769-1773 (2000).
43. Timchenko, L. T. et al. Identification of a (CUG)- triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24, 4407-4414 (1996).
44. Philips, A. V., Timchenko, L. T. & Cooper, T. A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737-741 (1998).
45. Darnell, R. B. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc. Natl Acad. Sci. USA 93, 4529-4536 (1998).
46. Musunuru, K. & Darnell, R. B. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu. Rev. Neurosci. (in the press).
47. Yang, Y. Y., Yin, G. L. & Darnell, R. B. The neuronal RNA- binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc. Natl Acad. Sci. USA 95, 13254-13259 (1998).
48. Ostareck, D. H. et al. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15- lipoxygenase translation from the 3' end. Cell 89, 597-606 (1999).
49. Kiledjian, M., Wang, X. & Liebhaber, S. A. Identification of two KH domain proteins in the a-globin mRNP stability complex. EMBO J. 14, 4357-4364 (1995).
50. Deshler, J. O., Highett, M. I., Abramson, T. & Schnapp, B. J. A highly conserved RNA-binding protein for cytoplasmic mRNA localization in vertebrates. Curr. Biol. 8, 489-496 (2000).
51. Ross, A. F., Oleynikov, Y., Kislauskis, E. H., Taneja, K. L. & Singer, R. H. Characterization of a p-actin mRNA zipcode- binding protein. Mol. Cell. Biol. 17, 2158-2165 (1997).
52. Pieretti, M. et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817-822 (1991).
53. De Boulle, K. et al. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet. 3, 31-35 (1993).
54. Min, H., Turck, C. W., Nikolic, J. M. & Black, D. L. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev. 11, 1023-1036 (1997).
55. Arning, S., Gruter, P., Bilbe, G. & Kramer, A. Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. RNA 2, 794-810 (1996).
56. Siebel, C. W., Admon, A. & Rio, D. C. Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. Genes Dev. 9, 269-283 (1995).
57. Engebrecht, J. A., Voelkel-Meiman, K. & Roeder, G. S. Meiosis-specific RNA splicing in yeast. Cell 66, 1257-1268 (1991).
58. Buckanovich, R. J. & Darnell, R. B. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17, 3194-3201 (1997).
59. Jensen, K. B., Musunuru, K., Lewis, H. A., Burley, S. K. & Darnell, R. B. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc. Natl Acad. Sci. USA 97, 5740-5755 (2000).
60. Lewis, H. A. et al. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell 100, 323-332 (2000).
61. Grabowski, P. J. Genetic evidence for a Nova regulator of alternative splicing in the brain. Neuron 25, 254-256 (2000).
62. Dalmau, J., Graus, F., Rosenblum, M. K. & Posner, J. B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 71, 59-72 (1992).
63. Graus, F., Cordon-Cardo, C. & Posner, J. B. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35, 538-543 (1985).
64. Dalmau, J., Furneaux, H. M., Cordon-Cardo, C. & Posner, J. B. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 141, 881-886 (1992).
65. Okano, H. J. & Darnell, R. B. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J. Neurosci. 17, 3024-3037 (1997).
66. Szabo, A. et al. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67, 325-333 (1991).
67. Keene, J. D. Why is Hu where? Shuttling of early-response- gene messenger RNA subsets. Proc. Natl Acad. Sci. USA 96, 5-7 (1999).
68. Brennan, C. M. & Steitz, J. A. HuR and mRNA stability. Cell. Mol. Life Sci. (in the press).
69. Robinow, S., Campos, A. R., Yao, K. M. & White, K. The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science 242, 1570-1572 (1988).
70. Koushika, S. P., Lisbin, M. J. & White, K. ELAV, a Drosophila neuron-specific protein, mediates the generation of an alternatively spliced neural protein isoform. Curr. Biol. 6, 1634-1641 (1996).
71. Koushika, S. P., Soller, M. & White, K. The neuron-enriched splicing pattern of Drosophila erect wing is dependent on the presence of ELAV protein. Mol. Cell. Biol. 20, 1836-1845 (2000).
72. Manley, G. T., Smitt, P. S., Dalmau, J. & Posner, J. B. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann. Neurol. 38, 102-110 (1995).
73. Zhang, L., Ashiya, M., Sherman, T. G. & Grabowski, P J. Essential nucleotides direct neuron-specific splicing of y-2 pre-mRNA. RNA 2, 682-698 (1996).
74. Wang, Z. & Grabowski, P. J. Cell- and stage-specific splicing events resolved in specialized neurons of the rat cerebellum. RNA 2, 1241-1253 (1996).
75. Ashiya, M. & Grabowski, P. J. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA 3, 996-1015 (1997).
76. Zhang, L., Liu, W. & Grabowski, P. J. Coordinate repression of a trio of neuron-specific splicing events by the splicing regulator PTB. RNA 5, 117-130 (1999).
77. Chan, R. C. & Black, D. L. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol. Cell. Biol. 17, 4667-4676 (1997).
78. Chan, R. C. & Black, D. L. Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro. Mol. Cell. Biol. 15, 6377-6385 (1995).
79. Grabowski, P. J. Splicing regulation in neurons: tinkering with cell-specific control. Cell 92, 709-712 (1998).
80. Chou, M. Y., Rooke, N., Turck, C. W. & Black, D. L. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol. Cell. Biol. 19, 69-77 (1999).
81. Polydorides, A. D., Okano, H. J., Yang, Y. Y., Stefani, G. & Darnell, R. B. A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of nova to regulate neuron- specific alternative splicing. Proc. Natl Acad. Sci. USA 97, 6350-6355 (2000).
82. Vezzani, A., Speciale, C., Della Vedova, F., Tamburin, M. & Benatti, L. Alternative splicing at the C-terminal but not at the N-terminal domain of the NMDA receptor NR1 is altered in the kindled hippocampus. Eur. J. Neurosci. 7, 2513-2517 (1995).
83. Daoud, R., Da Penha Berzaghi, M., Siedler, F., Hubener, M. & Stamm, S. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 11, 788-802 (1999).
84. Okabe, S., Miwa, A. & Okado, H. Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit. J. Neurosci. 19, 7781-7792 (1999).
85. Tingley, W. G., Roche, K. W., Thompson, A. K. & Huganir, R. L. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 364, 70-73 (1993).
86. Kanopka, A. et al. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393, 185-187 (1998).
87. Cao, W., Jamison, S. F. & Garcia-Blanco, M. A. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. RNA 3, 1456-1467 (1997).
88. Xiao, S. H. & Manley, J. L. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 11, 334-344 (1997).
89. Petersen-Mahrt, S. K. et al. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 18, 1014-1024 (1999).
90. Missler, M. & Sudhof, T. C. Neurexins: three genes and 1001 products. Trends Genet. 14, 20-26 (1998).
91. Schmucker, D. et al. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101, 671-684 (2000).
92. Kohmura, N. et al. Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron 20, 1137-1151 (1998).
93. Wu, Q. & Maniatis, T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97, 779-790 (1999).
94. Sugino, H. et al. Genomic organization of the family of CNR cadherin genes in mice and humans. Genomics 63, 75-87 (2000).
95. Smith, C. W. & Valcarcel, J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25, 381-388 (2000).
96. Hertel, K. J., Lynch, K. W. & Maniatis, T. Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 9, 350-357 (1997).
97. Staley, J. P. & Guthrie, C. Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell 92, 315-326 (1998).